These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 29484558)

  • 1. Targeting Inflammatory Vasculature by Extracellular Vesicles.
    Wang S; Dong X; Gao J; Wang Z
    AAPS J; 2018 Feb; 20(2):37. PubMed ID: 29484558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High yield, scalable and remotely drug-loaded neutrophil-derived extracellular vesicles (EVs) for anti-inflammation therapy.
    Gao J; Wang S; Wang Z
    Biomaterials; 2017 Aug; 135():62-73. PubMed ID: 28494264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation, purification and engineering of extracellular vesicles and their biomedical applications.
    Gao J; Dong X; Wang Z
    Methods; 2020 May; 177():114-125. PubMed ID: 31790730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular blebs: Artificially-induced extracellular vesicles for facile production and clinical translation.
    Thone MN; Kwon YJ
    Methods; 2020 May; 177():135-145. PubMed ID: 31734187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
    Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
    Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outer membrane vesicles for vaccination and targeted drug delivery.
    Wang S; Gao J; Wang Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Mar; 11(2):e1523. PubMed ID: 29701017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous cancer cell-derived extracellular vesicles as drug-delivery systems: a systematic review of preclinical and clinical findings and translational implications.
    Li YJ; Wu JY; Hu XB; Wang JM; Xiang DX
    Nanomedicine (Lond); 2019 Feb; 14(4):493-509. PubMed ID: 30694095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles.
    Nasiri Kenari A; Cheng L; Hill AF
    Methods; 2020 May; 177():103-113. PubMed ID: 31917274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Trends in the Application of Extracellular Vesicles as Novel Oral Delivery Vehicles for Therapeutics in Inflammatory Diseases.
    Zeng M; Liu M; Tao X; Yin X; Shen C; Wang X
    Int J Nanomedicine; 2024; 19():8573-8601. PubMed ID: 39185348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicles as an efficient nanoplatform for the delivery of therapeutics.
    Liu C; Gao H; Lv P; Liu J; Liu G
    Hum Vaccin Immunother; 2017 Nov; 13(11):2678-2687. PubMed ID: 28949786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Vesicles as Biological Shuttles for Targeted Therapies.
    Raimondo S; Giavaresi G; Lorico A; Alessandro R
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicle-based Nanotherapeutics: Emerging frontiers in anti-inflammatory therapy.
    Tang TT; Wang B; Lv LL; Liu BC
    Theranostics; 2020; 10(18):8111-8129. PubMed ID: 32724461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles.
    Melling GE; Carollo E; Conlon R; Simpson JC; Carter DRF
    Eur J Pharm Biopharm; 2019 Nov; 144():50-56. PubMed ID: 31419585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of Membrane-Derived Nanovesicles by Nitrogen Cavitation for Drug Targeting Delivery and Immunization.
    Gao J; Lee M; Dong X; Wang Z
    Methods Mol Biol; 2022; 2394():575-589. PubMed ID: 35094347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.
    Sil S; Dagur RS; Liao K; Peeples ES; Hu G; Periyasamy P; Buch S
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):422-442. PubMed ID: 31456107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are extracellular vesicles new hope in clinical drug delivery for neurological disorders?
    Muhammad SA
    Neurochem Int; 2021 Mar; 144():104955. PubMed ID: 33412233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of Hybrid Extracellular Vesicles by Fusion with Functionalized Liposomes.
    Piffoux M; Silva AKA; Gazeau F; Tareste D
    Methods Mol Biol; 2022; 2473():385-396. PubMed ID: 35819777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
    Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
    J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Functional Heterogeneity of Neutrophil-Derived Extracellular Vesicles Reflects the Status of the Parent Cell.
    Kolonics F; Szeifert V; Timár CI; Ligeti E; Lőrincz ÁM
    Cells; 2020 Dec; 9(12):. PubMed ID: 33353087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.